Gene signatures associated with barrier dysfunction and infection in oral lichen planus identified by analysis of transcriptomic data

PLoS One. 2021 Sep 10;16(9):e0257356. doi: 10.1371/journal.pone.0257356. eCollection 2021.

Abstract

Oral lichen planus (OLP) is one of the most prevalent oral mucosal diseases, but there is no cure for OLP yet. The aim of this study was to gain insights into the role of barrier dysfunction and infection in OLP pathogenesis through analysis of transcriptome datasets available in public databases. Two transcriptome datasets were downloaded from the Gene Expression Omnibus database and analyzed as whole and as partial sets after removing outliers. Differentially expressed genes (DEGs) upregulated in the dataset of OLP versus healthy epithelium were significantly enriched in epidermal development, keratinocyte differentiation, keratinization, responses to bacterial infection, and innate immune response. In contrast, the upregulated DEGs in the dataset of the mucosa predominantly reflected chemotaxis of immune cells and inflammatory/immune responses. Forty-three DEGs overlapping in the two datasets were identified after removing outliers from each dataset. The overlapping DEGs included genes associated with hyperkeratosis (upregulated LCE3E and TMEM45A), wound healing (upregulated KRT17, IL36G, TNC, and TGFBI), barrier defects (downregulated FRAS1 and BCL11A), and response to infection (upregulated IL36G, ADAP2, DFNA5, RFTN1, LITAF, and TMEM173). Immunohistochemical examination of IL-36γ, a protein encoded by one of the DEGs IL36G, in control (n = 7) and OLP (n = 25) tissues confirmed the increased expression of IL-36γ in OLP. Collectively, we identified gene signatures associated with hyperkeratosis, wound healing, barrier defects, and response to infection in OLP. IL-36γ, a cytokine involved in both wound repair and antimicrobial defense, may be a possible therapeutic target in OLP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cell Differentiation / drug effects
  • Cytokines / metabolism
  • Down-Regulation
  • Female
  • Gene Expression Profiling*
  • Gene Expression Regulation*
  • Humans
  • Immunity, Innate / drug effects
  • Immunohistochemistry
  • Keratins / drug effects
  • Lichen Planus, Oral / genetics*
  • Lichen Planus, Oral / metabolism*
  • Male
  • Middle Aged
  • Receptors, Interleukin-1 / antagonists & inhibitors
  • Receptors, Interleukin-1 / metabolism
  • Transcriptome*
  • Up-Regulation
  • Wound Healing / drug effects

Substances

  • Cytokines
  • IL1RL2 protein, human
  • Receptors, Interleukin-1
  • Keratins

Grants and funding

This study was supported by the National Research Foundation of Korea (Daejun, Korea) through the grants 2018R1A5A2024418 and 2020R1A2C2007038 awarded to Youngnim Choi and 2019R1A2C1002350 awarded to Sun Shim Choi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.